Squarepoint’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Buy |
189,569
+132,121
| +230% | +$3.05M | ﹤0.01% | 838 |
|
|
2025
Q1 | $1.55M | Buy |
57,448
+16,272
| +40% | +$439K | ﹤0.01% | 1290 |
|
|
2024
Q4 | $2.2M | Buy |
41,176
+25,034
| +155% | +$1.34M | ﹤0.01% | 1113 |
|
|
2024
Q3 | $733K | Sell |
16,142
-16,720
| -51% | -$760K | ﹤0.01% | 1582 |
|
|
2024
Q2 | $1.38M | Sell |
32,862
-10,289
| -24% | -$431K | ﹤0.01% | 1226 |
|
|
2024
Q1 | $1.62M | Sell |
43,151
-18,017
| -29% | -$678K | ﹤0.01% | 1130 |
|
|
2023
Q4 | $656K | Buy |
61,168
+50,521
| +475% | +$542K | ﹤0.01% | 1550 |
|
|
2023
Q3 | $107K | Sell |
10,647
-17,133
| -62% | -$173K | ﹤0.01% | 2243 |
|
|
2023
Q2 | $330K | Buy |
27,780
+14,613
| +111% | +$173K | ﹤0.01% | 1823 |
|
|
2023
Q1 | $159K | Buy |
+13,167
| New | +$159K | ﹤0.01% | 1928 |
|